» Articles » PMID: 8654449

Lack of Additive Effect Between Mechanisms of Resistance to Carbapenems and Other Beta-lactam Agents in Pseudomonas Aeruginosa

Overview
Publisher Springer
Date 1995 Nov 1
PMID 8654449
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Eighty-nine clinical isolates resistant (n = 61) or susceptible (n = 28) to imipenem and exhibiting the main patterns of susceptibility to other beta-lactam agents (wild type pattern, penicillinase pattern, constitutive cephalosporinase pattern) were studied in order to investigate (i) the mechanism of resistance involved and (ii) whether resistance to carbapenems affects the level of resistance to other beta-lactam agents and, conversely, if resistance to other beta-lactam agents affects the level of resistance to carbapenems. For this purpose, the presence of OprD protein in the cell wall was detected by Western blot and beta-lactamase activity by spectrophotometric assay and isoelectric focusing. OprD expression was not detectable in the imipenem-resistant (MIC > or = 16 micrograms/ml) strains. It was decreased in half the strains for which MICs of imipenem were 2 to 8 micrograms/ml and was close to a normal level in the most susceptible strains (MIC < or = 1 microgram/ml), thus demonstrating a direct correlation between the level of susceptibility to imipenem and the level of OprD expression. No imipenemase activity was detected in imipenem-resistant strains. Synergy between imipenem or meropenem and BRL 42715 was observed for all of the strains, demonstrating the role of cephalosporinase in carbapenem resistance. Within each pattern of susceptibility, the mean MICs of beta-lactam agents other than carbapenems were similar, whether the strains were susceptible or resistant to imipenem. Conversely, the mean MICs of imipenem or meropenem for either the imipenem-resistant or the imipenem-susceptible strains were similar, regardless of the susceptibility of these strains to the other beta-lactam agents. Thus, when several mechanisms of resistance to beta-lactam agents are present in the same strain of Pseudomonas aeruginosa, there is no additive effect between these mechanisms.

Citing Articles

Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.

Ocampo-Sosa A, Cabot G, Rodriguez C, Roman E, Tubau F, Macia M Antimicrob Agents Chemother. 2012; 56(4):1703-13.

PMID: 22290967 PMC: 3318371. DOI: 10.1128/AAC.05451-11.


Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.

Donay J, Mathieu D, Fernandes P, Pregermain C, Bruel P, Wargnier A J Clin Microbiol. 2004; 42(4):1542-6.

PMID: 15071001 PMC: 387561. DOI: 10.1128/JCM.42.4.1542-1546.2004.


Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples.

Joyanes P, Conejo M, Martinez-Martinez L, Perea E J Clin Microbiol. 2001; 39(9):3247-53.

PMID: 11526158 PMC: 88326. DOI: 10.1128/JCM.39.9.3247-3253.2001.


Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.

Mouneimne H, Robert J, Jarlier V, Cambau E Antimicrob Agents Chemother. 1998; 43(1):62-6.

PMID: 9869566 PMC: 89021. DOI: 10.1128/AAC.43.1.62.


Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study).

Jarlier V, Fosse T, Philippon A Intensive Care Med. 1996; 22(10):1057-65.

PMID: 8923070 DOI: 10.1007/BF01699228.

References
1.
Livermore D . Carbapenemases. J Antimicrob Chemother. 1992; 29(6):609-13. DOI: 10.1093/jac/29.6.609. View

2.
Nikaido H, NIKAIDO K, Harayama S . Identification and characterization of porins in Pseudomonas aeruginosa. J Biol Chem. 1991; 266(2):770-9. View

3.
Trias J, Nikaido H . Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1990; 34(1):52-7. PMC: 171519. DOI: 10.1128/AAC.34.1.52. View

4.
Jarlier V, Nicolas M, Fournier G, Philippon A . Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988; 10(4):867-78. DOI: 10.1093/clinids/10.4.867. View

5.
Nordmann P, Mariotte S, Naas T, Labia R, Nicolas M . Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother. 1993; 37(5):939-46. PMC: 187856. DOI: 10.1128/AAC.37.5.939. View